Top compounds associated with response to FGL2


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 6e-05
mRNA tandutinib CTRPv2 pan-cancer AAC 0.14 7e-05
mRNA AZ628 GDSC1000 pan-cancer AAC 0.19 9e-05
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 9e-05
mRNA Ki8751 CTRPv2 pan-cancer AAC 0.13 0.0001
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0001
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0001
mRNA Sunitinib CTRPv2 pan-cancer AAC 0.13 0.0001
mRNA Nutlin-3 CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA Sunitinib GDSC1000 pan-cancer AAC 0.19 0.0002
Download CSV